Paula Bates

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Murphy EM, Centner CS, Bates PJ, et al. (2020) Delivery of thymoquinone to cancer cells with as1411-conjugated nanodroplets. Plos One. 15: e0233466
Vivanco-Rojas O, García-Bermúdez MY, Iturriaga-Goyon E, et al. (2020) Corneal neovascularization is inhibited with nucleolin-binding aptamer, AS1411. Experimental Eye Research. 193: 107977
Reyes-Reyes EM, Bates PJ. (2019) Characterizing Oligonucleotide Uptake in Cultured Cells: A Case Study Using AS1411 Aptamer. Methods in Molecular Biology (Clifton, N.J.). 2036: 173-186
Bates PJ, Reyes-Reyes EM, Malik MT, et al. (2016) G-quadruplex oligonucleotide AS1411 as a cancer-targeting agent: Uses and mechanisms. Biochimica Et Biophysica Acta
Malik MT, O'Toole MG, Casson LK, et al. (2015) AS1411-conjugated gold nanospheres and their potential for breast cancer therapy. Oncotarget
Reyes-Reyes EM, Šalipur FR, Shams M, et al. (2015) Mechanistic studies of anticancer aptamer AS1411 reveal a novel role for nucleolin in regulating Rac1 activation. Molecular Oncology. 9: 1392-405
Šalipur FR, Reyes-Reyes EM, Xu B, et al. (2014) A novel small molecule that induces oxidative stress and selectively kills malignant cells. Free Radical Biology & Medicine. 68: 110-21
Reyes-Reyes EM, Jin Z, Vaisberg AJ, et al. (2013) Physangulidine A, a withanolide from Physalis angulata, perturbs the cell cycle and induces cell death by apoptosis in prostate cancer cells. Journal of Natural Products. 76: 2-7
Reyes-Reyes EM, Teng Y, Bates PJ. (2010) A new paradigm for aptamer therapeutic AS1411 action: uptake by macropinocytosis and its stimulation by a nucleolin-dependent mechanism. Cancer Research. 70: 8617-29
Choi EW, Nayak LV, Bates PJ. (2010) Cancer-selective antiproliferative activity is a general property of some G-rich oligodeoxynucleotides. Nucleic Acids Research. 38: 1623-35